Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

AstraZeneca
Mallinckrodt
Dow
Moodys
Johnson and Johnson
Medtronic

Last Updated: December 14, 2019

DrugPatentWatch Database Preview

PANRETIN Drug Profile

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

When do Panretin patents expire, and what generic alternatives are available?

Panretin is a drug marketed by Concordia and is included in one NDA.

The generic ingredient in PANRETIN is alitretinoin. There are two drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the alitretinoin profile page.

Drug patent expirations by year for PANRETIN
Drug Prices for PANRETIN

See drug prices for PANRETIN

Pharmacology for PANRETIN
Drug ClassRetinoid
Synonyms for PANRETIN
(2E,4E,6Z,8E)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid
(2E,4E,6Z,8E)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexenyl)nona-2,4,6,8-tetraenoic acid
(2E,4E,6Z,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenoic acid
(2E,4E,6Z,8E)-3,7-Dimethyl-9-(2,6,6-trimethylcyclohex-1-enyl)nona-2,4,6,8-tetraenoic acid
(2E,4E,6Z,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenoic acid
(2E,4E.6Z,8E)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexan-1-yl)-2,4,6,8-nonatetraenoic acid
(7E,9Z,11E,13E)-retinoic acid
(9cis)-retinoic acid
[3H]-9-cis-retinoic acid
[3H]9-cis-retinoic acid
15-Apo-beta-caroten-15-oate
1UA8E65KDZ
2,4,6,8-Nonatetraenoic acid, 3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-, (2E,4E,6Z,8E)-
300R038
42156-EP2295426A1
42156-EP2295427A1
42156-EP2311808A1
42156-EP2311829A1
42156-EP2311840A1
5300-03-8
9 Cis Retinoic Acid
9-(Z)-retinoic Acid
9-cis RA
9-cis Retinoic Acid
9-cis-RA
9-cis-Retinoate
9-CIS-RETINOIC ACID
9-CIS-RETINOIC ACID (SEE RETINOID PROJECT 6)
9-cis-Retinoic acid, >=98% (HPLC)
9-cis-Tretinoin
9-CRA
9-Retinoate
9-Retinoic acid
9(Z)-Retinoic acid
9C-RA
9CRA
AC1L9MT9
Acide retinoique (French) (DSL)
AGN 192013
AGN-192013
AJ-63024
AKOS005622553
Alitretinoin
Alitretinoin (USAN)
Alitretinoin [USAN:INN:BAN]
Alitretinoin [USAN]
Alitretinoin|||Retinoid analogues
alitretinoina
alitretinoine
alitretinoinum
all-trans- Vitamin A1 acid
All-trans-b-retinoate
all-trans-b-Retinoic acid
All-trans-beta-retinoate
alpha-acido (argentina)
alpha-vitaminsyre [denmark]
ALRT 1057
ALRT-1057
ALRT1057
Atragen
B-retinoate
BAL-4079
BAL4079
BB 0261656
BDBM31892
beta-Retinoate
BML2-E06
BRD-K35483542-001-02-3
BSPBio_001495
C15493
CAS-5300-03-8
CCG-208266
CCRIS 7098
CHEBI:50648
CHEMBL705
D02815
DB00523
DSSTox_CID_20404
DSSTox_GSID_40404
DSSTox_RID_79490
DTXSID6040404
GTPL2645
GTPL5383
HMS1361K17
HMS1791K17
HMS1989K17
HMS3402K17
HSDB 7186
IDI1_033965
Isotretinoin retinoate
Isotretinoin Retinoic acid
LG-100057
LG100057
LGD 100057
LGD 1057
LGD-1057
LGD1057
LMPR01090022
LS-1328
MFCD00270072
MolPort-002-507-281
NCGC00161590-01
NCGC00161590-02
NCGC00161590-03
NCGC00161590-04
NCGC00161590-05
NCGC00161590-06
NCGC00161590-07
NCGC00255697-01
NSC 659772
NSC-659772
NSC659772
Panretin (TN)
Panretin Gel
Panretyn
Panrexin
Retin A (TN)
Retinoic acid, 9-cis-
Retinoic acid, cis-9,trans-13-
Retinova
Ro-04-4079
SCHEMBL18666
SHGAZHPCJJPHSC-ZVCIMWCZSA-N
Spectrum5_001935
SR-05000013784
SR-05000013784-1
STK801887
Toctino
Tox21_302195
trans-Retinoate
trans-Vitamin a acid
Tretinoin (JAN/USP)
Tretinoin (TN)
Tretinoin [USAN:BAN:INN]
Tretinoin/all-trans retinoate
tretinoine (French) (EINECS)
UNII-1UA8E65KDZ
UPCMLD-DP097:001
UPCMLD-DP097:002
W-200595
ZINC12661824

US Patents and Regulatory Information for PANRETIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Concordia PANRETIN alitretinoin GEL;TOPICAL 020886-001 Feb 2, 1999 RX Yes Yes   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
AstraZeneca
Colorcon
Johnson and Johnson
Boehringer Ingelheim
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.